CD44 and pancreatic neoplasm: In pancreatic cancer, CSCs were first reported in 2007 as a subpopulation of CD44(+)/CD24(+)/ESA(+) or CD133(+)/CXCR4(+) cancer cells [21,22], and many CSCs have been identified using these three methods [23].